This page will host Events plug-in for all Clarion and trade events.

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

193.69 +4.91 (+2.60%)

Streaming Delayed Price Updated: 11:33 AM EST, Jan 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	65,093
Open	188.38
Bid (Size)	192.84 (100)
Ask (Size)	194.19 (100)
Prev. Close	188.78
Today's Range	186.26 - 194.42
52wk Range	93.58 - 212.49
Shares Outstanding	16,676,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗

November 18, 2025

Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model.

Via Investor's Business Daily

This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗

November 17, 2025

A high-conviction fund just trimmed one of its biggest winners—here’s what long-term investors should make of the move.

Via The Motley Fool

Performance

YTD	+1.9%	+1.9%
1 Month	+0.4%	+0.4%
3 Month	+7.1%	+7.1%
6 Month	+55.8%	+55.8%
1 Year	+83.0%	+83.0%

More News

Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗

November 17, 2025

Via The Motley Fool

This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗

November 17, 2025

Via The Motley Fool

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

November 10, 2025

From Orchestra BioMed Holdings, Inc.

Via GlobeNewswire

EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch ↗

November 07, 2025

Via Benzinga

Ligand (LGND) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Via The Motley Fool

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

Via MarketMinute

Ligand Pharmaceuticals (NASDAQ:LGND) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance ↗

November 06, 2025

Via Chartmill

What's Next: Ligand Pharmaceuticals's Earnings Preview ↗

November 05, 2025

Via Benzinga

Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance

September 22, 2025

Via MarketMinute

What Analysts Are Saying About Ligand Pharmaceuticals Stock ↗

September 02, 2025

Via Benzinga

Ligand (LGND) Q2 Revenue Jumps 15% ↗

August 07, 2025

Via The Motley Fool

Ligand Pharmaceuticals (NASDAQ:LGND) Surpasses Q2 2025 Earnings Estimates with Strong Royalty Growth ↗

August 07, 2025

Via Chartmill

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

July 31, 2025

From Orchestra BioMed Holdings, Inc.

Via GlobeNewswire

Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts ↗

July 10, 2025

Via Stocktwits

Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease ↗

July 10, 2025

Via Benzinga

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings ↗

April 17, 2025

Via Benzinga

Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s Elated ↗

April 17, 2025

Via Stocktwits

Dow Falls Over 1%; US Initial Jobless Claims Decline ↗

April 17, 2025

Via Benzinga

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity ↗

April 17, 2025

Via Benzinga

Frequently Asked Questions

Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?

Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.

What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?

Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?

The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market

What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?

The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 193.69

When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?

The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 01/14/26 11:33 AM ET

What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?

The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 3.23B

How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?

Ligand Pharmaceuticals Incorporated - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.